Learn about the latest advances in inflammatory bowel disease (IBD) and advanced endoscopic procedures from the experts of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai. Ever since Burrill Crohn, MD, and colleagues described the condition now known as Crohn’s disease, Mount Sinai gastroenterologists have been on the cutting edge of diagnosing and treating IBD. Our Susan and Leonard Feinstein IBD Clinical Center, led by Jean-Frederic Colombel, MD, and Marla Dubinsky, MD, is at the forefront of research into the causes of IBD and leads the field in clinical trials that have changed the way patients are cared for. Additionally, at our Center for Advanced Colonoscopy and Therapeutic Endoscopy at Sinai (CACTES), led by Christopher DiMaio, MD, our physicians are pioneering new tools and techniques to identify, diagnose, and treat the most complex digestive disorders.
Latest Videos| View More >
See what makes our Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center unique.
Advances in FMT
Helping patients with IBD
Personalizing IBD treatment
Understanding IBD and the microbiome
Managing Crohn's disease
The Future of IBD treatment
Helping patients with pancreatitis
African Americans experience low rates of colorectal cancer screening
Advances in Barrett's Esophagus
Colon cancer screening: what to look for
COVID-19: Implications on Inflammatory Bowel Disease
In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures.
Ustekinumab is more effective than placebo as an induction and maintenance therapy for UC.
New research in the disruptions in the GI tract of HIV-1 patients
Population analysis on IBD in Western Countries
Study of infants born to mothers with IBD